The Cancer Research Institute (CRI) Clinic and Laboratory Integration Program (CLIP) 2027 supports team-based translational research that connects laboratory discovery with clinical application in cancer immunology and immunotherapy.
The 2027 theme is Primary and Secondary Cancer Prevention and Interception, with a focus on developing immune-based strategies to prevent primary cancer development or recurrence following successful treatment.
Eligibility Criteria
- Applicants must hold a faculty appointment at the level of tenure-track assistant professor or higher by the time the award begins.
- Researchers at U.S. and international institutions may apply.
- There are no citizenship restrictions.
- For-profit institutions are not eligible.
- Projects must involve a team-based approach combining complementary scientific and clinical expertise.
- Each team should include a Lead Principal Investigator and Co-Investigators.
Funding Details
- Funding: Up to $1,000,000
- Duration: 3 years
- Indirect costs of up to 10% are provided in addition to the award.
Deadline
- LOI deadline: December 1, 2026
- Applicants invited to submit full proposals: by the end of January 2027
- Full proposal deadline: March 1, 2027
- Earliest award activation: July 1, 2027
- Applications are due by 11:59 PM ET.
Further Information
- Clinical trials are not funded through this mechanism.
- Applications are submitted electronically through the CRI online application system.
- Official CRI CLIP Program